Peter Marks

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In
Peter Marks
Peter Marks
Executive Director, Executive Chairman / Iris Metals
Most Notable Role

Peter Marks has over 30 years of experience in corporate advisory and investment banking; specialising in capital raising IPOs, cross-border M&A transactions, corporate underwriting, and venture capital transactions for companies in Australia, the US and Israel.

He has been involved in a broad range of transactions with a special focus in the life sciences, biotechnology, medical technology and the high tech segments.

Mr Marks is also an experienced company director of several entities listed on the ASX, NASDAQ, and AIM markets.

He holds an MBA from the University of Edinburgh; and a Bachelor of Economics, Bachelor of Laws and a Graduate Diploma
in Commercial Law from Monash University.

Lists and Charts

Roles

2023
Non-Executive Director
Evergreen Lithium
2020
Executive Director, Executive Chairman
Iris Metals
2017
Non-Executive Director
Nyrada Inc
Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
627th Actinogen Medical">Actinogen Medical 14.13% -8.42%
628th Central Petroleum">Central Petroleum 13.97% -20.17%
629th Alterity Therapeutics">Alterity Therapeutics 13.95% -30.54%
630th Waypoint REIT">Waypoint REIT 13.74% 4.45%
631st Platinum Capital">Platinum Capital 13.69% 1.79%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

31/08/24
Other
Alterity Therapeutics
27/08/24
$20.65k Bought
Iris Metals
30/06/24
Other
Iris Metals
Total value as at the date of the transaction
Powered by Morningstar ®

      Person Activity

      Peter Marks
      		NEW ROLE: Executive Director, Executive Chairman, Iris Metals 31 Jul 2024
      Peter Marks
      		NEW ROLE: Non-Executive Director, Evergreen Lithium 25 Jul 2024
      Peter Marks
      		NEW ROLE: Non-Executive Director, Nyrada Inc 03 Nov 2020
      Peter Marks
      		NEW ROLE: Non-Executive Director, Deputy Chair, Noxopharm 03 Nov 2020
      Peter Marks
      		NEW ROLE: Non-Executive Director, Alterity Therapeutics 03 Nov 2020

      News Articles

    Related Information

    Access to our data for Peter Marks is only available to paid subscribers with Data & Insights access.

    Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

    Peter Marks is linked to 11 organisations which are included in 1 list - Public Companies - non WA.

    To see the data you will need to Subscribe.

    X